
Checkpoint Inhibitor–Associated Arthritis
Author(s) -
Nina Ghosh,
Michael D Tiongson,
Carolyn Stewart,
Karmela Kim Chan,
Bridget Jivanelli,
Laura C. Cappelli,
Anne R. Bass
Publication year - 2020
Publication title -
journal of clinical rheumatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.615
H-Index - 50
eISSN - 1536-7355
pISSN - 1076-1608
DOI - 10.1097/rhu.0000000000001370
Subject(s) - polymyalgia rheumatica , medicine , monoarthritis , oligoarthritis , polyarthritis , rheumatoid arthritis , arthritis , adverse effect , myalgia , rheumatoid factor , inflammatory arthritis , dermatology , disease , vasculitis , giant cell arteritis
We performed a systematic literature review to identify all reports of immune checkpoint inhibitor-associated inflammatory arthritis to describe it phenotypically and serologically.